Transferability of genetic risk scores in African populations.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
06 2022
Historique:
received: 18 08 2021
accepted: 20 04 2022
pubmed: 3 6 2022
medline: 22 6 2022
entrez: 2 6 2022
Statut: ppublish

Résumé

The poor transferability of genetic risk scores (GRSs) derived from European ancestry data in diverse populations is a cause of concern. We set out to evaluate whether GRSs derived from data of African American individuals and multiancestry data perform better in sub-Saharan Africa (SSA) compared to European ancestry-derived scores. Using summary statistics from the Million Veteran Program (MVP), we showed that GRSs derived from data of African American individuals enhance polygenic prediction of lipid traits in SSA compared to European and multiancestry scores. However, our GRS prediction varied greatly within SSA between the South African Zulu (low-density lipoprotein cholesterol (LDL-C), R

Identifiants

pubmed: 35654908
doi: 10.1038/s41591-022-01835-x
pii: 10.1038/s41591-022-01835-x
pmc: PMC9205766
doi:

Substances chimiques

Cholesterol, LDL 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1163-1166

Subventions

Organisme : Medical Research Council
ID : MRC-RFA-SHIP01/2015
Pays : United Kingdom
Organisme : Department of Health
ID : CL-2020-1.0.6-001
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U01 HG011717
Pays : United States
Organisme : Wellcome Trust
ID : 214205/Z/18/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220740/Z/20/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_1204/16
Pays : United Kingdom
Organisme : FIC NIH HHS
ID : U2R TW010673
Pays : United States
Organisme : British Heart Foundation
ID : RE/18/4/34215
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Sanna, S. et al. Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLOS Genet. 7, e1002198 (2011).
doi: 10.1371/journal.pgen.1002198
Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274–1283 (2013).
doi: 10.1038/ng.2797
Asselbergs, F. W. et al. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am. J. Hum. Genet. 91, 823–838 (2012).
doi: 10.1016/j.ajhg.2012.08.032
Willer, C. J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161–169 (2008).
doi: 10.1038/ng.76
Chasman, D. I. et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLOS Genet. 5, e1000730 (2009).
doi: 10.1371/journal.pgen.1000730
Kathiresan, S. et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40, 189–197 (2008).
doi: 10.1038/ng.75
Lu, X. et al. Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat. Genet. 49, 1722–1730 (2017).
doi: 10.1038/ng.3978
Liu, D. J. et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat. Genet. 49, 1758–1766 (2017).
doi: 10.1038/ng.3977
Hoffmann, T. J. et al. A large electronic-health-record-based genome-wide study of serum lipids. Nat. Genet. 50, 401–413 (2018).
doi: 10.1038/s41588-018-0064-5
Duncan, L. et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat. Commun. 10, 1–9 (2019).
doi: 10.1038/s41467-019-11112-0
Lewis, C. M. & Vassos, E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 12, 1–11 (2020).
doi: 10.1186/s13073-020-00742-5
Gomez, F., Hirbo, J. & Tishkoff, S. A. Genetic variation and adaptation in Africa: implications for human evolution and disease. Cold Spring Harb. Perspect. Biol. 6, a008524 (2014).
doi: 10.1101/cshperspect.a008524
Márquez-Luna, C., Loh, P.-R., South Asian Type 2 Diabetes (SAT2D) Consortium, SIGMA Type 2 Diabetes Consortium & Price, A. L. Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet. Epidemiol. 41, 811–823 (2017).
Bentley, A. R., Callier, S. L. & Rotimi, C. N. Evaluating the promise of inclusion of African ancestry populations in genomics. NPJ Genom. Med. 5, 1–9 (2020).
doi: 10.1038/s41525-019-0111-x
Bloetzer, C. et al. Screening for cardiovascular disease risk factors beginning in childhood. Public Health Rev. 36, 1–9 (2015).
doi: 10.1186/s40985-015-0011-2
Cavazos, T. B. & Witte, J. S. Inclusion of variants discovered from diverse populations improves polygenic risk score transferability. Hum. Genet. Genomics Adv. 2, 100017 (2021).
doi: 10.1016/j.xhgg.2020.100017
Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584–591 (2019).
doi: 10.1038/s41588-019-0379-x
Johnson, L., Zhu, J., Scott, E. R. & Wineinger, N. E. An examination of the relationship between lipid levels and associated genetic markers across racial/ethnic populations in the multi-ethnic study of atherosclerosis. PLOS One 10, e0126361 (2015).
doi: 10.1371/journal.pone.0126361
Lucchese, B. Implications of African genetic diversity. Nat. Rev. Nephrol. 5, 663–663 (2009).
doi: 10.1038/nrneph.2009.202
Yu, N. et al. Larger genetic differences within Africans than between Africans and Eurasians. Genetics 161, 269–274 (2002).
doi: 10.1093/genetics/161.1.269
Hird, T. R. et al. Study profile: the Durban Diabetes Study (DDS): a platform for chronic disease research. Glob. Health Epidemiol. Genom. 1, e2 (2016).
doi: 10.1017/gheg.2015.3
Gurdasani, D. et al. Uganda Genome Resource enables insights into population history and genomic discovery in Africa. Cell 179, 984–1002 (2019).
doi: 10.1016/j.cell.2019.10.004
Sugiuchi, H. et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin. Chem. 41, 717–723 (1995).
doi: 10.1093/clinchem/41.5.717
Sugiuchi, H. et al. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate. Clin. Chem. 44, 522–531 (1998).
doi: 10.1093/clinchem/44.3.522
Klarin, D. et al. Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program. Nat. Genet. 50, 1514–1523 (2018).
doi: 10.1038/s41588-018-0222-9
Choi, S. W. & O’Reilly, P. F. PRSice-2: polygenic risk score software for biobank-scale data.Gigascience 8, giz082 (2019).
doi: 10.1093/gigascience/giz082
R Core Team. R: a language and environment for statistical computing https://www.R-project.org/ (R Foundation for Statistical Computing, 2019).
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, 2009). https://doi.org/10.1007/978-0-387-98141-3

Auteurs

Abram B Kamiza (AB)

The African Computational Genomics (TACG) Research Group, MRC/UVRI and LSHTM, Entebbe, Uganda.
Malawi Epidemiology and Intervention Research Unit, Lilongwe, Karonga, Malawi.
Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Sounkou M Toure (SM)

The African Computational Genomics (TACG) Research Group, MRC/UVRI and LSHTM, Entebbe, Uganda.
African Centre of Excellence in Bioinformatics, University of Science and Technologies of Bamako, Bamako, Mali.

Marijana Vujkovic (M)

Department of Pathology and Molecular Medicine, McMaster University, Michael G. DeGroote School of Medicine, Hamilton, Ontario, Canada.

Tafadzwa Machipisa (T)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
Hatter Institute for Cardiovascular Diseases Research in Africa (HICRA), Department of Medicine, University of Cape Town, Cape Town, South Africa.
Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton, Ontario, Canada.

Opeyemi S Soremekun (OS)

The African Computational Genomics (TACG) Research Group, MRC/UVRI and LSHTM, Entebbe, Uganda.

Christopher Kintu (C)

The African Computational Genomics (TACG) Research Group, MRC/UVRI and LSHTM, Entebbe, Uganda.

Manuel Corpas (M)

Cambridge Precision Medicine Limited, ideaSpace, University of Cambridge Biomedical Innovation Hub, Cambridge, United Kingdom.
Institute of Continuing Education, Madingley Hall, University of Cambridge, Cambridge, UK.
Facultad de Ciencias de la Salud, Universidade Internacional de La Rioja, Madrid, Spain.

Fraser Pirie (F)

Department of Diabetes and Endocrinology, University of KwaZulu-Natal, Durban, South Africa.

Elizabeth Young (E)

Omnigen Biodata Ltd, Cambridge, UK.

Dipender Gill (D)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George's, University of London, London, UK.

Manjinder S Sandhu (MS)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Pontiano Kaleebu (P)

MRC/UVRI and LSHTM, Entebbe, Uganda.

Moffat Nyirenda (M)

MRC/UVRI and LSHTM, Entebbe, Uganda.

Ayesha A Motala (AA)

Department of Diabetes and Endocrinology, University of KwaZulu-Natal, Durban, South Africa.

Tinashe Chikowore (T)

Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. tinashe.chikowore1@wits.ac.za.
MRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. tinashe.chikowore1@wits.ac.za.

Segun Fatumo (S)

The African Computational Genomics (TACG) Research Group, MRC/UVRI and LSHTM, Entebbe, Uganda. segun.fatumo@lshtm.ac.uk.
MRC/UVRI and LSHTM, Entebbe, Uganda. segun.fatumo@lshtm.ac.uk.
London School of Hygiene and Tropical Medicine, London, UK. segun.fatumo@lshtm.ac.uk.
H3Africa Bioinformatics Network (H3ABioNet) Node, Centre for Genomics Research and Innovation, NABDA/FMST, Abuja, Nigeria. segun.fatumo@lshtm.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH